FDA-Approved Alopecia Treatments Explained
FDA-approved treatments are reshaping the battle against alopecia areata, an autoimmune condition impacting millions. Recent approvals of Janus kinase inhibitors like baricitinib, ritlecitinib, and deuruxolitinib offer promising pathways for hair regrowth and improved quality of life. Navigating these therapies’ benefits, efficacy, and risks is essential for patients seeking effective management options. Understanding FDA-Approved Treatments for […]
3 minute read
 
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
            